Summary |
|
||||||||
Variant origin |
|
||||||||
Variant description |
|
||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:211010Epidermolysis Bullosa (EB) encompasses a spectrum of mechanobullous disorders caused by rare mutations that result in structural weakening of the skin and mucous membranes. 129X1/SvJ mice homozygous for the hypomorphic Lamc2jeb mutation develop a progressive form of junctional EB (JEB) characterized most obviously by blistering and scarring of the ears and tails as the result of separations within the dermal-epidermal basement membrane (BM). To address whether modifier genes influence this syndrome, the authors conducted a survey of mouse strain background effects. They first generated 129X1/SvJ mice homozygous for the hypomorphic Lamc2jeb mutation, referred to as 129X1/SvJ-Lamc2jeb mice. These 129X1/SvJ-Lamc2jeb mice were backcrossed 10 generations onto four other strain backgrounds: C57BL/6J, DBA/1J, FVB/NJ, and MRL/MpJ, giving rise to the following congenic strains: B6J.129X1-Lamc2jeb, D1.129X1-Lamc2jeb, FVB.129X1-Lamc2jeb, and MRL.129X1-Lamc2jeb.Cohorts of Lamc2jeb/jeb males from each strain were aged, visually inspected weekly, and quantitatively scored for the severity of ear and tail lesions. Striking differences in the age of onset and the intensity of these lesions among the strains were observed, with the MRL/MpJ background showing the earliest onset, followed by C57BL/6J and DBA/1J, 129X1/SvJ, and with FVB/NJ being most resistant. Similar strain patterns were observed for females, though with delayed onset and less susceptibility to tail lesions.To determine the inheritance patterns of susceptibility and resistance, the authors analyzed Lamc2jeb/jeb progeny from an F1 cross of the most susceptible (MRL/MpJ) and most resistant (FVB/NJ) strain backgrounds. These results were consistent with co-dominant inheritance. Immunofluorescence imaging of tail skin confirmed separation at the plane of the lamina lucida in 78 wk old male MRL-Lamc2jeb/jeb mice, which was not apparent at this age in FVB-Lamc2jeb/jeb mice. Crosses were made between phenotypically disparate strains to map the modifiers. Two groups of F2 Lamc2jeb/jeb homozygotes were produced: (D1.129X1-Lamc2jeb x 129X1/SvJ-Lamc2jeb)F2-Lamc2jeb/Lamc2jeband(B6J.129X1-Lamc2jeb x FVB.129X1-Lamc2jeb)F2-Lamc2jeb/Lamc2jeb,with >200 mice per group. For analysis, the F2 datasets were combined to increase the statistical power. Given that males develop disease before females, there was a strong sexual dimorphism (Prob > chi<2> 3.9 x 10<-11>.The most robust QTL (prob > chi<2> = 7.96 x 10<-7>), replicated in both mouse crosses independent of sex and explaining 5.6% of the genetic variance, was located on Chromosome 19 with a 95% confidence interval of 34.50 cM peaking at 42 cM (GRCm38). This QTL, named Ebm1 (Epidermolysis Bullosa modifier 1), has a peak LOD score of approximately 8.2.To more directly address the contributions of the Ebm1 QTL, the Lamc2 |
||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|